title: [Outcome of renal transplantation in patients with chronic virus hepatitis].
abstract: The objective is to present results of renal transplantation in patients with end-stage renal disease and chronic virus C/B hepatitis. We retrospectively reviewed outcome of transplantation in patients having received renal allograft from 1985 to 2009 at Zagreb University Hospital Center: graft function, graft and patient survival, hepatic function, and complications of transplantation, i.e. episodes of acute rejection, manifestation of diabetes mellitus, and proteinuria. There were 91 patients, 50 men and 41 women, mean age 40.9. Patients were previously treated with dialysis for 7.8 years, with the mean follow-up after transplantation of 7.3 years. The most frequent diagnoses of end-stage renal disease were chronic glomerulonephritis, reflux nephropathy, tubulointerstitial nephritis, renal hypoplasia/aplasia, and polycystic renal disease. Good graft function (creatinine 200 micromol/L) was recorded in 59.5% of patients. One-year, 5-year and 10-year graft survival was 93%, 64% and 39%, and 1-year, 5-year and 10-year patient survival after transplantation was 98%, 72% and 42%, respectively. Normal values of liver chemistry (AST, ALT) were found in 59.5% and elevated values in 40.5% of patients. Episodes of acute rejection occurred in 56% of patients. Proteinuria was recorded in 27%, diabetes mellitus in 18% and elevated blood pressure in 66% of patients. Patients with chronic C/B virus hepatitis having undergone renal transplantation had worse graft function and worse graft and patient survival than patients without chronic hepatitis. The most common causes of death were cardiovascular diseases, cerebrovascular diseases and cirrhosis hepatitis.
authors.affiliation: Odjel za nefrologiju i dijalizu, Opća bolnica Sibenik, Klinicki bolnicki centar Zagreb, Interna klinika, Zavod za nefrologiju, arterijsku hipertenziju i dijalizu, Zagreb, Hrvatska. marijanag@hi.t-com.hr
authors.forename: Marijana
authors.initials: M
authors.lastname: Gulin
authors.forename: Jasna
authors.initials: J
authors.lastname: Slavicek
authors.forename: Nikolina
authors.initials: N
authors.lastname: Basić-Jukić
authors.forename: Petar
authors.initials: P
authors.lastname: Kes
authors.forename: Zvonko
authors.initials: Z
authors.lastname: Puretić
authors.forename: Ljubica
authors.initials: L
authors.lastname: Bubić-Filipi
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D003404:Creatinine / Q000097:blood; D005260:Female; D006085:Graft Survival; D019694:Hepatitis B, Chronic / Q000150:complications*; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000601:surgery; D016030:Kidney Transplantation / Q000009:adverse effects; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D055815:Young Adult
chemical_list: D003404:Creatinine